Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnerships
MedTech
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
The goal will be to provide an end-to-end platform that applies extra-long nanopore sequencing reads to whole genomes.
Conor Hale
Mar 15, 2024 3:10pm
Genmab's growth plan entails partnering less, owning more: CEO
Mar 14, 2024 9:40am
Silence loses Mallinckrodt collab, wins in cardiovascular ph. 2
Mar 13, 2024 8:54am
GSK, Vir end flu drug alliance, removing key piece of $345M pact
Feb 23, 2024 5:10am
4 Big Pharmas recruit Biofourmis for cancer trials
Feb 14, 2024 3:30pm
BMS signs $674M biobucks pact with VantAI for molecular glues
Feb 13, 2024 11:00am